Search Results - "Kouvelakis, K."

The use of first, second and beyond line chemotherapy for metastatic pancreatic ductal adenocarcinoma at the Royal Marsden Hospital by Butters, O., Swann, F., Leslie, I., Young, K., Kouvelakis, K., Watkins, D., Rao, S., Chau, I., Cunningham, D., Starling, N.

Get full text

Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric (OG) cancer: A pooled analysis of four randomised trials by Davidson, M., Wagner, A.D., Kouvelakis, K., Starling, N., Chau, I., Watkins, D., Rao, S., Peckitt, C., Cunningham, D.

Get full text

Treatment of relapsed oesophagogastric adenocarcinoma after perioperative chemotherapy and surgery by Davidson, M., Butler, C., Butters, O., Fong, C., Turkes, F., Cafferkey, C., Kouvelakis, K., Cunningham, D., Watkins, D., Rao, S., Starling, N., Chau, I.

Get full text

Identification of a nanostring signature that differentiates early pancreatic cancers according to stromal composition and predicts clinical outcome by Sclafani, F., Cascione, L., Cunningham, D., Young, K., Carotenuto, P., Fassan, M., Salati, M., Lanese, A., Berenguer Pina, J., Kouvelakis, K., Vendrell, I., Said-Huntingford, I., Previdi, M., Begum, R., Gillbanks, A., Hedayat, S., Sadanandam, A., Lampis, A., Hahne, J., Valeri, N., Chau, I., Braconi, C.

Get full text

EGFR amplification (amp) and survival in the REAL-3 trial by Smyth, E., Kouvelakis, K., Cunningham, D., Hahne, J.C., Peckitt, C., Vlachogiannis, G., Watkins, D., Rao, S., Starling, N., Wilson, S.H., Waddell, T.S., Okines, A., Crosby, T., Mansoor, W., Wadsley, J., Middleton, G., Wotherspoon, A., Chau, I., Valeri, N.

Get full text

P-398The use of first, second and beyond line chemotherapy for metastatic pancreatic ductal adenocarcinoma at the Royal Marsden Hospital by Butters, O, Swann, F, Leslie, I, Young, K, Kouvelakis, K, Watkins, D, Rao, S, Chau, I, Cunningham, D, Starling, N

Get full text

619PD_PRInfluence of sex on chemotherapy efficacy and toxicity in oesophagogastric (OG) cancer: A pooled analysis of four randomised trials by Davidson, M, Wagner, A D, Kouvelakis, K, Starling, N, Chau, I, Watkins, D, Rao, S, Peckitt, C, Cunningham, D

Get full text

P-201Treatment of relapsed oesophagogastric adenocarcinoma after perioperative chemotherapy and surgery by Davidson, M, Butler, C, Butters, O, Fong, C, Turkes, F, Cafferkey, C, Kouvelakis, K, Cunningham, D, Watkins, D, Rao, S, Starling, N, Chau, I

Get full text

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of response to DNA damage by Lampis, A., Carotenuto, P., Hedayat, S., Previdi, M.C., Zito, D., Sclafani, F., Parisi, C., Hahne, J.C., Hallsworth, A., Kirkin, V., Young, K., Kouvelakis, K., Azevedo, S.X., Vasiliki, M., Scarpa, A., Cunningham, D., Chau, I., Valeri, N., Fassan, M., Braconi, C.

Get full text

Rash, neutrophil-lymphocyte ratio (NLR) and survival in the REAL3 trial by Smyth, E.C., Kouvelakis, K., Peckitt, C., Waddell, T., Watkins, D., Rao, S., Starling, N., Saffery, C., Okines, A.F., Chau, I., Cunningham, D.

Get full text

Survival in advanced oesophagogastric adenocarcinoma (OGA) improves with the use of multiple lines of therapy: Results from an analysis of over 500 patients (pts) by Cafferkey, C., Davidson, M., Goode, E., Hughes, D., Reguera, P., Kalaitzaki, R., Kouvelakis, K., Peckitt, C., Chau, I., Watkins, D., Rao, S., Cunningham, D., Starling, N.

Get full text

ATM loss, MSI and survival in the MAGIC trial by Smyth, E., Fassan, M., Kouvelakis, K., Nankivell, M., Peckitt, C., Wotherspoon, A., Valeri, N., Rugge, M., Allum, W., Langley, R., Cunningham, D.

Get full text

646PEGFR amplification (amp) and survival in the REAL-3 trial by Smyth, E, Kouvelakis, K, Cunningham, D, Hahne, J C, Peckitt, C, Vlachogiannis, G, Watkins, D, Rao, S, Starling, N, Wilson, S H, Waddell, T S, Okines, A, Crosby, T, Mansoor, W, Wadsley, J, Middleton, G, Wotherspoon, A, Chau, I, Valeri, N

Get full text

14PModulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of response to DNA damage by Lampis, A, Carotenuto, P, Hedayat, S, Previdi, M C, Zito, D, Sclafani, F, Parisi, C, Hahne, J C, Hallsworth, A, Kirkin, V, Young, K, Kouvelakis, K, Azevedo, S X, Vasiliki, M, Scarpa, A, Cunningham, D, Chau, I, Valeri, N, Fassan, M, Braconi, C

“…Abstract Background FOLFIRINOX-regime is a combination-chemotherapy that provides the best clinical benefit in pancreatic ductal adenocarcinoma (PDAC)…”
Get full text

PD-003Identification of a nanostring signature that differentiates early pancreatic cancers according to stromal composition and predicts clinical outcome by Sclafani, F, Cascione, L, Cunningham, D, Young, K, Carotenuto, P, Fassan, M, Salati, M, Lanese, A, Berenguer Pina, J, Kouvelakis, K, Vendrell, I, Said-Huntingford, I, Previdi, M, Begum, R, Gillbanks, A, Hedayat, S, Sadanandam, A, Lampis, A, Hahne, J, Valeri, N, Chau, I, Braconi, C

Get full text

Real world use of palliative systemic therapy (tx) in elderly patients (pts) with metastatic colorectal cancer (mCRC) within a UK specialist cancer centre by Khakoo, S., Georgiou, A., Hughes, D., Lanese, A., Baratelli, C., Coakley, M., Shepherd, S., Calamai, V., Kouvelakis, K., Kalaitzaki, R., Ring, A., Chau, I., Watkins, D., Rao, S., Cunningham, D., Starling, N.

Get full text

FCγRIIa and FCγRIIIa single nucleotide polymorphisms (SNPs) and cetuximab benefit in the EXCITE trial by Sclafani, F., Gollins, S., Cunningham, D., Hulkki Wilson, S., Kouvelakis, K., Lopes, A., West, N., Quirke, P., Begum, R., Valeri, N., Beare, S., Hughes, L., Gonzalez De Castro, D., Chau, I.

Get full text

Real world use of palliative systemic therapy (tx) in patients (pts) with metastatic early onset colorectal cancer (mEOCRC) within a UK specialist cancer centre by Georgiou, A., Khakoo, S., Minchom, A., Kouvelakis, K., Kalaitzaki, R., Nobar, N., Calamai, V., Ifijen, M., Lethby, M., Arouri, F., Chau, I., Watkins, D., Rao, S., Cunningham, D., Starling, N.

Get full text